Navigating the complexities of pharmaceutical trademarks

Maury M. Tepper, III
Co-founder and Principal
Tepper & Eyster
Emmanuelle Ragon
Senior Legal Director, Head of Trade Marks

Clearing and protecting pharmaceutical trademarks presents a host of challenges unique to this industry. Minimizing the risk of brand confusion isn’t just a matter of consumer convenience—it is critical for protecting patient safety. In this webinar, two experienced trademark practitioners examine the complexities of the pharma trademark process and how trademark professionals can minimize the risk of rejection.

Topics Include:
– Product and trademark development cycles unique to pharmaceuticals 
– The multi-layered clearance process and the differing perspectives of the trademark office and regulatory agencies
– The “inverted pyramid” naming process for pharma brands
– Strategies for trademark research and assessing search results
– Tips for aligning stakeholders—from R&D and marketing to legal and regulatory
As a result of improvements we are making to SERION, the platform will be unavailable Saturday May 8th from 7am CEST/1am EDST until Saturday midnight CEST/6pm EDST. We apologize for any inconvenience.